TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer

Marc Pujalte Martin, Delphine Borchiellini, Brice Thamphya, Aline Guillot, Jean-Baptiste Paoli, Dominique Besson, Werner Hilgers, Frank Priou, Claude El Kouri, Benjamin Hoch, Jean-Laurent Deville, Renaud Schiappa, Sandrine Cheli, Gérard Milano, Jean-François Tanti, Frédéric Bost, Jean-Marc Ferrero

Open source

DOI: 10.1016/j.clgc.2021.08.008
Published: 2021-12
Container: Clinical Genitourinary Cancer
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.clgc.2021.08.008,
  title = {TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer},
  author = {Marc Pujalte Martin and Delphine Borchiellini and Brice Thamphya and Aline Guillot and Jean-Baptiste Paoli and Dominique Besson and Werner Hilgers and Frank Priou and Claude El Kouri and Benjamin Hoch and Jean-Laurent Deville and Renaud Schiappa and Sandrine Cheli and Gérard Milano and Jean-François Tanti and Frédéric Bost and Jean-Marc Ferrero},
  year = {2021},
  journal = {Clinical Genitourinary Cancer},
  doi = {10.1016/j.clgc.2021.08.008},
  url = {https://doi.org/10.1016/j.clgc.2021.08.008}
}

RIS

TY  - JOUR
TI  - TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer
AU  - Marc Pujalte Martin
AU  - Delphine Borchiellini
AU  - Brice Thamphya
AU  - Aline Guillot
AU  - Jean-Baptiste Paoli
AU  - Dominique Besson
AU  - Werner Hilgers
AU  - Frank Priou
AU  - Claude El Kouri
AU  - Benjamin Hoch
AU  - Jean-Laurent Deville
AU  - Renaud Schiappa
AU  - Sandrine Cheli
AU  - Gérard Milano
AU  - Jean-François Tanti
AU  - Frédéric Bost
AU  - Jean-Marc Ferrero
PY  - 2021
JO  - Clinical Genitourinary Cancer
DO  - 10.1016/j.clgc.2021.08.008
UR  - https://doi.org/10.1016/j.clgc.2021.08.008
ER  -

APA

Martin, M. P., Borchiellini, D., Thamphya, B., Guillot, A., Paoli, J., Besson, D., Hilgers, W., Priou, F., Kouri, C. E., Hoch, B., Deville, J., Schiappa, R., Cheli, S., Milano, G., Tanti, J., Bost, F., & Ferrero, J. (2021). TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer. https://doi.org/10.1016/j.clgc.2021.08.008

Source records

crossref · retrieved 2026-09-27T03:11:07.705Z